The founder of Abcam is to revive his campaign to clear out the board of the life sciences company and will seek to relist the business in the UK.
Jonathan Milner, who remains one of the largest shareholders with a 6.1 per cent stake, plans to vote against a $5.7 billion takeover from Danaher, the $187 billion US conglomerate, which was announced last month.
Milner, 58, said that he would formally request a shareholder meeting in an attempt to replace the board, including the chief executive, chief financial officer and chairman. He said other shareholders and analysts shared his belief that the $24-per-share offer "substantially undervalues" the biotechnology firm that he founded 25 years ago.
"When considering the potential of the company as an independent
Comments
Post a Comment